The US Food and Drug Administration is closely monitoring the risk of tumor formation in other similar adeno-associated virus vector-based gene therapy programs.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.